Related Experiment Video
Updated: Jun 12, 2025
08:49
A 3D Organotypic Melanoma Spheroid Skin Model
Published on: May 18, 2018
15.7K
Primary rectal malignant melanoma with schistosomiasis
Zhimeng Cheng1,2, Chao Wang3, Yulong Cai1,2
1Division of Biliary Surgery, Department of General Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Intractable & Rare Diseases Research
|June 9, 2025
Summary
This case study presents a rare instance of primary rectal malignant melanoma co-occurring with schistosomiasis. The patient achieved a 5-year disease-free survival following targeted therapy, suggesting potential treatment avenues for this rare condition.
Area of Science:
- Gastroenterology
- Oncology
- Infectious Diseases
Background:
- Primary rectal malignant melanoma is exceptionally rare, with limited reported cases.
- Schistosomiasis co-infection with rectal melanoma is exceedingly uncommon.
- Rectal malignant melanoma has a high mortality rate, with limited established treatment protocols.
Discussion:
- This report details a unique case of a 79-year-old female with primary rectal malignant melanoma and *Schistosoma japonicum* infection.
- The patient underwent radical rectal resection followed by targeted therapy with Dabrafenib and Trametinib.
- Successful 5-year disease-free survival was achieved, offering insights into managing this rare dual diagnosis.
Key Insights:
- The successful treatment highlights the potential efficacy of targeted therapies like Dabrafenib and Trametinib in managing advanced rectal melanoma.
- The presence of *Schistosoma japonicum* in the tumor warrants further investigation into its role in melanoma development or progression.
- This case underscores the importance of comprehensive diagnostic workups for rare gastrointestinal malignancies.
Outlook:
- Further research is needed to elucidate the complex relationship between schistosomiasis and the development of melanoma.
- Investigating novel therapeutic strategies for rare rectal cancers co-infected with parasitic diseases is crucial.
- Long-term follow-up studies are essential to assess the durability of response to targeted therapies in similar cases.
